Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 12821–12840 of 17,529 recalls

June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Testosterone Bi-Blend 50 mg/ml + Estradiol Valerate 2.5 mg/ml Injectable

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Morphine 30 mg/ml Solution

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Fentanyl 7

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Tri-Mix (25/2.5/10) Injectable

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Sermorelin/GHRP6 1000/1000 mcg/ml Injection

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Folic Acid 5 mg/ml Injection

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Sermorelin 300 mcg/ml + GHRP-2 300 mcg/ml Injection

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: LIPO-EXTREME Injectable

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Nandrolone Decanoate 200 mg/ml Injection

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Oxytocin 100 units/ml Injection

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Sermorelin/GHRP2 1000/1000 mcg/ml Injection

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Morphine 30 mg/ml + Clonidine 250 mcg/ml Solution

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Fentanyl 1

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Buckshot Injectable

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Morphine 30 mg/ml + Bupivacaine 5 mg/ml Solution

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Morphine 50 mg/ml + Fentanyl 3

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: LIPO-Tropic Injectable

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Tri-Mix (17.7/0.59/6) (MFG) Injectable

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Hydroxocobalamin 10 mg/ml Folic Acid 4 mg/ml Injectable

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
June 2, 2015· The Compounding Pharmacy of America

Recalled Item: Tri-Mix ST4/PGE 2/LIDO 2 0.1/0.05/0.05 Injectable

The Issue: Lack of Assurance of Sterility; FDA inspection identified

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund